Objective To evaluate the clinical efficacy of Chai-Zhi Ping-Gan decoction combined with Xiao-Pi Kuan-Wei decoction in the treatment of liver-stomach disharmony type chronic gastritis. Methods A total of 94 patients with liver-stomach disharmony type chronic gastritis admitted to No.215 Hospital of Shaanxi Nuclear Industry from January 2020 to April 2023 were included and were divided into a study group and a control group by stratified random sampling method, with 47 cases in each group. In the control group, there were 24 males and 23 females, aged (44.81±5.62) years, with a duration of disease of (2.60±1.35) years. In the study group, there were 23 males and 24 females, aged (45.20±5.47) years, with a duration of disease of (2.56±1.24) years. The control group received standard quad therapy, esomeprazole magnesium enteric-coated tablets, amoxicillin tablets, furazolidone tablets, and bismuth potassium citrate capsules for 2 weeks, after stopping the use of amoxicillin tablets, furazolidone tablets, and bismuth potassium citrate capsules, and continued to take esomeprazole magnesium enteric-coated tablets for 2 weeks. The study group received Chai-Zhi Ping-Gan decoction combined with Xiao-Pi Kuan-Wei decoction treatment. The treatment course of both groups was 4 weeks. The clinical efficacy, traditional Chinese medicine (TCM) symptom score, gastrointestinal function indexes [somatostatin (SST), gastrin (GAS), motilin (MTL), and vasoactive intestinal peptide (VIP)], inflammatory markers [interleukin-6 (IL-6), high-sensitivity C-reactive protein (hs-CRP), and tumor necrosis factor α (TNF-α)], disappearance time of abdominal pain, acid reflux, and belching, and eradication rate of Helicobacter pylori (Hp) of the two groups were compared. Statistical methods used were t test and χ2 test. Results The total effective rate of clinical treatment in the study group was higher than that in the control group [97.87% (46/47) vs. 85.11% (40/47)], with a statistically significant difference (χ2=4.919, P=0.027). After 4 weeks of treatment, the total TCM symptom score in the study group was (3.70±0.53), and that in the control group was (5.52±0.79), with a statistically significant difference (t=13.116, P<0.001); the levels of SST, GAS, MTL, and VIP in the study group were (299.60±20.18) ng/L, (81.38±6.15) ng/L, (51.60±6.28) ng/L, and (22.35±2.79) ng/L, and those in the control group were (200.19±17.96) ng/L, (70.18±5.62) ng/L, (43.57±5.65) ng/L, and (26.16±4.15) ng/L, with statistically significant differences (t=25.228, 9.216, 6.517, and 5.223, all P<0.001); the levels of IL-6, hs-CRP, and TNF-α in the study group were (22.52±7.16) µg/L, (10.65±1.46) mg/L, and (1.50±0.28) µg/L, which were lower than those in the control group [(35.51±7.74) µg/L, (15.88±2.18) mg/L, and (1.94±0.34) µg/L], with statistically significant differences (t=8.446, 13.666, and 6.849, all P<0.001). The disappearance time of abdominal pain, acid reflux, and belching in the study group were (3.57±2.02) d, (3.01±1.11) d, and (3.47±1.33) d, and those in the control group were (7.72±3.57) d, (8.07±3.64) d, and (7.02±4.02) d, with statistically significant differences (t=6.936, 9.116, and 5.748, all P<0.001). Within 30 d after withdrawal, the eradication rate of Hp in the study group was higher than that in the control group [95.74% (45/47) vs. 82.95% (39/47)], with a statistically significant difference (χ2=4.029, P=0.045). Conclusion Chai-Zhi Ping-Gan decoction combined with Xiao-Pi Kuan-Wei decoction shows significant clinical efficacy in the treatment of liver-stomach disharmony type chronic gastritis, effectively improves the patients' symptoms and physiological indicators, and increases the Hp eradication rate, proving to be a safe and effective treatment choice.